Epstein Secrets

ER ANL AL BRUIT GALA BENEFIT CO-CHAIRS Michele and Timothy Barakett Lisa and Jeff Blau Emily and Len Blavatntk Dr. Ronald and Beth Dozoretz Dr. Eva Andersson•Dubin and Glenn Dubin Julie Anne Quay and Matthew J. Edmonds Sonia and Paul Tudor Jones II Ornella and Robert Morrow Elisa Port. MD and Jeffrey Port.

Len Blavatntk Dr. Ronald and Beth Dozoretz Dr. Eva Andersson•Dubin and Glenn Dubin Julie Anne Quay and Matt

e DBC and the communities we serve. We are also proud to recognize Steven J. Burakoff, MD, who was recently appointed Dean for Cancer Innovation at the Icahn School of Medicine at Mount Sinai. Dr. Burakoff will work closely with School and Health System hospital leaders to identify and support opportunities for innovative cancer research

From: Eva Dubin To: Jeffrey <[email protected]> Subject: FW: Let's discuss Date: Tue, 01 Apr 2014 14:29:31 +0000 Importance: Normal From: To: Subject: Let

negative breast cancer has yet to be found—to develop a blocking molecule or inhibitor. Recently however, a renowned medical team collaborating with the Icahn School of Medicine at Mount Sinai in New York City and with the ongoing support of science philanthropist, Jeffrey Epstein, have identified a possible triple negative receptor to tar

From: Eva Dubin < To: Jeffrey <[email protected]> Subject: FW: Sneak Preview of Dubin Breast Center Benefit Live Auction Date: Mon, 09 Dec 2013 16:41:54 +0000

dual's unique genetic makeup? "OBSERVERSHIP" PROGRAM Your up-and-coming super scientist will spend up to six weeks in a coveted -observership" at the Icahn School of Medicine at Mount Sinai, one of the highest- ranked academic medical centers in the nation. The -observer will have the rare opportunity to shadow and learn from experts fo